San Diego, CA, United States of America

Yu-Hsin Tom Lin

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Yu-Hsin Tom Lin

Introduction

Yu-Hsin Tom Lin is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceuticals and healthcare. With a total of 6 patents, Lin has focused on developing innovative compounds and methods aimed at treating various diseases and conditions.

Latest Patents

One of Lin's latest patents involves fatty acid analogues and methods of use. This patent provides compounds, pharmaceutical compositions, and methods for treating diseases such as cancer, including metastatic cancers. Additionally, the compounds are utilized for treating inflammatory diseases, cardiovascular diseases, autoimmune diseases, and dry eye syndrome. Another notable patent addresses methods of treating retinal binding protein (RBP4) related diseases using triazolopyridines. This patent includes heterocyclic derivative compounds and pharmaceutical compositions that are beneficial for treating conditions like obesity.

Career Highlights

Throughout his career, Yu-Hsin Tom Lin has worked with notable organizations such as Belite Bio, Inc. and Columbia University. His work has significantly impacted the development of therapeutic solutions in the medical field.

Collaborations

Lin has collaborated with esteemed colleagues, including Cheng-Chi Irene Wang and Konstantin Petrukhin, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yu-Hsin Tom Lin's innovative work and dedication to advancing medical treatments through his patents highlight his importance in the field of pharmaceuticals. His contributions continue to pave the way for new therapeutic approaches to complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…